Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Rheumatology Women's Health Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting Non-phase study NCT07740967

Dietary Supplements and Middle Aged Women (Collagen & Omega)

Dietary Supplements and Middle Aged Women (Collagen & Omega) — Recruiting • Non-phase study • Gastroenterology • NCT07740967.

📅 03 Aug 2026 ⏱ 1 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
Phase
Non-phase study
NCT ID
NCT07740967
Start
2026-05-01
Completion
2028-08-01
ClinicaliQ Trial Snapshot
  • Dietary Supplements and Middle Aged Women (Collagen & Omega) — Recruiting • Non-phase study • Gastroenterology • NCT07740967.
  • Collagen and omega supplements tested over 8 weeks to see if they improve joint pain, fatigue, sleep, and strength in middle-aged women.

Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

This study will examine the effects of combining different types of dietary supplements on various aspects of health and wellbeing in middle aged women. The main outcomes of the trial will be aspects of health and wellbeing that middle aged women report as increasingly problematic, such as joint pain, fatigue, sleep, and changes in body composition, strength, and inflammation. Participants will consume the supplement(s) or placebo for 8 weeks, and outcome measures will be assessed before and after supplementation. Conditions: Cognition, Inflammation Biomarkers, Bone Metabolism Biomarkers, Fatigue Symptom, Sleep, Body…

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Clinical Brief
I’ll lose my bowel because my pain was dismissed until my husband spoke up
Gastroenterology · BBC Health · 19 Jul 2026
Patient advocacy matters: Spousal involvement in clinical consultations increased credibility of symptom reporting and led to appropriate investigation of persistent postoperative pain…
View brief →
Guideline
Cirrhosis in Over 16s: Assessment and Management (NICE NG50)
Gastroenterology · 27 Mar 2026
Perform upper endoscopy to screen all cirrhosis patients for oesophageal varices; if present, offer variceal band ligation and initiate non-selective beta-blockers (propranolol…
View guideline →
Guideline
Coeliac Disease: Recognition, Assessment and Management (NICE NG20)
Gastroenterology · 27 Mar 2026
Test for coeliac disease using tissue transglutaminase (tTG) IgA antibodies as first-line serology, with concurrent total IgA measurement; if IgA deficient, use…
View guideline →
Clinical Brief
1 in 4 births in England now by emergency C-section
Gastroenterology · BBC Health · 05 Jun 2026
Emergency caesarean section rate in England has risen to 25% of all births, representing a marked increase over the past five years…
View brief →
Clinical Brief
‘We have to respond to women’s health needs more easily’
Gastroenterology · BBC Health · 11 May 2026
Women's Health Initiative - Key Takeaways Liverpool-based groups are addressing long-standing gaps in women's healthcare provision, highlighting systemic under-resourcing that requires urgent…
View brief →
Guideline
Acute Upper Gastrointestinal Bleeding in Over 16s (NICE CG141)
Gastroenterology · 27 Mar 2026
Use Glasgow-Blatchford score at initial assessment to stratify risk and determine whether patients can be managed as outpatients or require admission Insert…
View guideline →